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Abstract
In this investigation, we have carried out an autosomal genome-wide linkage analysis to map genes associated with type 2
diabetes (T2D) and five quantitative traits of blood lipids including total cholesterol, high-density lipoprotein (HDL)
cholesterol, low-density lipoprotein (LDL) cholesterol, very low-density lipoprotein (VLDL) cholesterol, and triglycerides in a
unique family-based cohort from the Sikh Diabetes Study (SDS). A total of 870 individuals (526 male/344 female) from 321
families were successfully genotyped using 398 polymorphic microsatellite markers with an average spacing of 9.26 cM on
the autosomes. Results of non-parametric multipoint linkage analysis using Sall statistics (implemented in Merlin) did not
reveal any chromosomal region to be significantly associated with T2D in this Sikh cohort. However, linkage analysis for lipid
traits using QTL-ALL analysis revealed promising linkage signals with p#0.005 for total cholesterol, LDL cholesterol, and HDL
cholesterol at chromosomes 5p15, 9q21, 10p11, 10q21, and 22q13. The most significant signal (p=0.0011) occurred at
10q21.2 for HDL cholesterol. We also observed linkage signals for total cholesterol at 22q13.32 (p=0.0016) and 5p15.33
(p=0.0031) and for LDL cholesterol at 10p11.23 (p=0.0045). Interestingly, some of linkage regions identified in this Sikh
population coincide with plausible candidate genes reported in recent genome-wide association and meta-analysis studies
for lipid traits. Our study provides the first evidence of linkage for loci associated with quantitative lipid traits at four
chromosomal regions in this Asian Indian population from Punjab. More detailed examination of these regions with more
informative genotyping, sequencing, and functional studies should lead to rapid detection of novel targets of therapeutic
importance.
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Introduction
Type 2 diabetes (T2D) is a major public health problem of 21
st
century and the fifth leading cause of death worldwide. According
to Global Burden of Disease Study predictions, India, China and
USA will be the top three leading countries for the prevalence of
diabetes [1]. The approximate estimate of 31.7 million people with
diabetes in India in 2000 will increase to 79.4 million by year 2030
and the size of the USA population with diabetes, both diagnosed
and undiagnosed, will rise from approximately 30 million now to
44 million by the year 2030 [2]. T2D is strongly linked to various
metabolic disturbances including obesity, insulin resistance,
dyslipidemias, and elevated blood pressure. Linkage and candi-
date-gene focused studies successfully identified some rare forms of
T2D controlled by one or two genes such as the various forms of
maturity onset diabetes of young (MODY), mitochondrial
diabetes, and neonatal diabetes. However, no single locus was
noted to have strong and consistent evidence of linkage with the
most common form of T2D in multiple populations [3].
Elevated serum lipid levels are important risk factors for the
development of cardiovascular disease (CVD). The genetic basis of
several monogenic forms of lipid disorders has been determined,
including familial lipoprotein lipase (LPL) deficiency, apoC-II
deficiency, defective apoB, familial hypercholesterolemia, and
familial triglyceridemia [4]. However, genes associated with
common forms of dyslipidemia in the general population remain
elusive.
Recent genome-wide association studies (GWAS) performed for
many complex traits are revolutionizing the dissection of genetic
determinants of several complex traits including T2D and serum
lipids. Although these studies are adding to the list of reliably
associated common loci controlling T2D and blood lipids and
even other complex traits, these loci explain only a small portion of
the heritable component associated with these complex diseases.
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21188Clearly, additional loci that can explain a large proportion of the
variation await discovery.
Asian Indians, one quarter of the global population, have
unusually high CVD mortality and very high prevalence of insulin
resistance and T2D [5]. The increased susceptibility to early onset
of T2D and premature CVD in Asian Indians was confirmed in
several earlier studies [6,7,8,9]. Indians tend to develop T2D at a
relatively earlier age of 40–45 that is about 10–15 year earlier than
European populations [6,10,11,12]. However, the reasons under-
lying the increased morbidity and mortality associated with T2D
and CVD and in people of South Asian ancestry are poorly
understood. In this investigation, we have carried out an
autosomal genome-wide linkage scan to map the genes associated
with T2D and serum lipid levels using our large family-based
cohort from the Sikh Diabetes Study (SDS) [13]. This non-
smoking, primarily vegetarian, endogamous caste group has high
prevalence of diabetes and CVD with young age-of-onset. To our
knowledge, this is the first report of genome-wide linkage studies
on T2D and quantitative lipid traits in a population from South
Asian Continent.
Methods
Study Population, Ascertainment Criteria, and
Recruitment
This study was carried out on an endogamous community of
Khatri Sikhs living in Northern Indian states of Punjab, Haryana,
and New Delhi. The Khatri population was chosen because of its
relatively higher prevalence of diabetes as compared to other Sikh
castes. Khatri Sikhs are more affluent and live in cities and are
traders by profession. In general, Sikhs do not smoke for religious
and cultural reasons and about 50% of the study participants are
life-long vegetarians. A total of 1,115 individuals from 338
families were extensively phenotyped [13]. DNA samples of 870
individuals (526 male/344 female) comprising 685 T2D cases and
185 normal glucose tolerant (NGT) relatives were successfully
genotyped and used in this investigation. The T2D cases were 25
years or older and mean age at the time of recruitment (mean 6
standard deviation [SD]) was 54.2611.0 years. Average age of
unaffected relative was 46.0614.7 years with a minimum age of
19 years. Only individuals who reported that all four grandpar-
ents were Khatri Sikhs of North Indian origin, who had Khatri
surnames, and who spoke the Punjabi language were included. In
addition, probands were required to have two or more full
siblings with diabetes, or at least one living parent, and more than
two siblings available for sampling. Excluded from the sample
were half-siblings, adopted individuals, and individuals of South,
East and Central Indian origin; individuals with type 1 diabetes
(T1D) or a family member with T1D; individuals with rare forms
of T2D such as maturity-onset diabetes of young (MODYs), or
secondary diabetes (e.g., due to hemochromatosis or pancreatitis).
Clinical characteristics of the SDS participants used for this
investigation are summarized in Table 1. All blood samples were
obtained at the baseline visit. All participants provided a written
consent following an informed consent procedures approved by
Institutional Review Boards (IRBs). All SDS protocols and
consent documents were reviewed and approved by the
University of Oklahoma Health Sciences Center (OUHSC)
(IRB # 13302, approved till August 31, 2011) and the University
of Pittsburgh (IRB # 021234) as well as the Human Subject
Protection (Ethical) committees at the participating hospitals and
institutes in India. The Ethical committees of local institutions in
India were Hero DMC Heart Institute, Ludhiana, and Guru
Nanak Dev University, Amritsar. Each Institute in India also
separately obtained Federal Wide Assurance (FWA) from the
Office of Human Research Protection (OHRP) from the US
Department of Health and Human Services (DHHS). All the key
investigators and key personnel working for SDS obtained online
training for Human Participant Protection Education for
Research.
SDS Families
A total of 557 families were investigated and 236 families were
excluded because they did not meet the eligibility criteria for the
study. A total of 321 families containing 870 individuals (526
male/344 females), who were successfully genotyped (call rate
.95%), were used for linkage analysis of T2D. These 321 diabetic
families comprised 275 affected sibling pairs, 59 affected cousin
pairs, 127 affected parent-child pairs, 1 affected grand parent-child
Table 1. Characteristics of Study Population Stratified by
Gender and Disease (Mean 6 SD).
T2D cases
Unaffected
Relatives p value**
685 (412M/273F) 185 (116M/69F)
Age at recruitment
(year)
M* 52.42611.36 44.71615.20 ,0.0001
F 55.93610.88 48.60613.60 ,0.0001
Age at onset (years) M 45.80610.65 – –
F 48.62610.40 – –
Duration of T2D
(years)
M 7.8267.42 – –
F 7.3366.65 – –
BMI (kg/m
2) M 26.9064.23 26.8964.53 0.876
F 28.5065.20 27.5864.79 0.140
WAIST (cm) M 95.50610.40 93.2611.55 0.040
F 92.70611.00 88.1610.60 ,0.0001
HIP (cm) M 95.868.20 96.068.50 0.875
F 99.3611.00 97.669.70 0.135
WHR
{ M 0.9960.07 0.9760.07 ,0.0001
F 0.9460.07 0.9060.07 ,0.0001
Fasting Glucose
(mg/dl)
M 185.81670.66 95.30611.38 ,0.0001
F 193.23674.58 97.7769.31 ,0.0001
Total Cholesterol
(mg/dl)
M 177.18644.34 174.54645.86 0.525
F 187.24647.42 177.58638.94 0.049
Triglycerides (mg/dl) M 197.636113.50 160.71685.49 ,0.0001
F 172.66695.34 155.74669.72 0.078
HDL-cholesterol
(mg/dl)
M 38.11612.44 39.21610.01 0.321
F 41.76612.59 43.70611.37 0.187
LDL-cholesterol
(mg/dl)
M 99.98635.68 98.36632.96 0.619
F 110.17639.81 102.89635.56 0.098
VLDL-cholesterol
(mg/dl)
M 39.75624.05 32.45618.43 0.001
F 34.77619.18 31.13613.84 0.056
*M - male, F- female;
{Waist to hip ratio; **Difference between T2D cases and
unaffected relatives.
doi:10.1371/journal.pone.0021188.t001
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6.5 participants per family with family size ranging from 3 to 105
members. The average number of generations per family was 2.5.
Of these 321 families, 316 families containing 846 individuals (511
male/335 female) were used in the linkage analysis of blood lipids
(Table 2).
Phenotypes
The diagnosis of T2D was confirmed by (a) searching medical
records for indications of symptoms of diabetes or measures of
blood glucose levels, (b) use of diabetic medication, and (c)
measuring fasting glucose levels following the guidelines of
American Diabetes Association [14]. A medical record indicating
either (1) a fasting plasma glucose level .126 mg/dl after a
minimum 12-h fast or (2) a 2-h post glucose level .200 mg/dl [2-h
oral glucose tolerance test (OGTT)] on more than one occasion
with symptoms of diabetes. In the absence of medical record
information, we confirmed self-reported T2D cases by performing
a 2-h OGTT. The 2-h OGTTs were performed following the
criteria of the World Health Organization (WHO) (75 g oral load
of glucose). The NGT diagnosis was based on a fasting glycemia
,108 mg/dl or a 2-h glucose ,140 mg/dl. The average age at
diagnosis was 47 years and duration of diabetes was about 7.5
years. Since T2D remains asymptomatic for several years, an
average Asian Indian patient with new onset of diabetes might
actually had diabetes 4–7 years before diagnosis [15]. This is in
sharp contrast to the mean age at onset of 60 years or above in
developed countries [10,11,16,17].
Body mass index (BMI) was calculated as [weight (kg)/height
(meter)
2], and waist-to-hip ratio (WHR) was calculated as the ratio
of abdomen or waist circumference to hip circumference. Despite
having comparable BMI (27.564.0 T2D cases vs. 27.364.7
controls), patients had a pronounced abdominal adiposity as
reflected by their significantly higher WHR (0.9760.07 vs.
0.9460.07; p,0.0001) than controls. Interestingly, WHR in
Khatri Sikh men (BMI 26–27 kg/m
2) was higher than obese
Mexican American men (BMI.32 kg/m
2); Sikhs (0.9760.05) vs.
Mexican Americans (0.9560.06) [18]. Perhaps central obesity is
the underlying cause of high risk to insulin resistance and high
prevalence of T2D and CVD in Indians.
Education (highest level completed) was scored 1–4 where 1=
primary or none, 2=high school, 3=bachelor degree, and 4=
post graduate degree. Job-grade was scored 1–3 based on
education and economic status where 1= high income, 2=
middle-income, 3= lower-middle and lowest income class;
category 1 was used as a reference group. Smoking information
was collected on past smoking, current smoking status, length of
time, number of cigarettes smoked/day. Alcohol consumption was
scored 0–4 where 0= no alcohol, 1= 50 to 100 ml/day, 2= 100
to 400 ml/day, 3= 400 to 1000 ml (1L)/day 4=.1 L/day.
Physical activity was scored 1–3 based on level of activity
performed where 1= very active, 2= moderately active, 3=
quite inactive. About 83% of T2D patients were taking oral
hypoglycemic agents. Some were maintaining glycemic control by
diet and exercise. The individuals on lipid-lowering medications
were not included in the analysis. Further recruitment details are
available elsewhere [13].
Metabolic Estimations
Serum lipids [total cholesterol, high-density lipoprotein (HDL)
cholesterol, low-density lipoprotein (LDL) cholesterol, very low-
density lipoprotein (VLDL) cholesterol, and triglycerides] were
quantified using standard enzymatic methods (Roche, Basel,
Switzerland). Fasting serum insulin was measured by radio-
immuno assay (Diagnostic Products, Cypress, USA). All quanti-
tative parameters were determined by following manufacturer’s
instructions using a Hitachi 902 auto-analyzer (Roche, Basel,
Switzerland).
Marker Genotyping
DNA was extracted from buffy coats using QiaAmp blood kits
(Qiagen, Chatworth, USA) or by the salting out procedure [19].
870 samples were successfully genotyped for 398 polymorphic
microsatellite markers with an average spacing of 9.26 cM on the
autosomes by the National Heart Lung and Blood Institute’s
(NHLBI) Mammalian Genotyping Service (http://www.
marshmed.org/genetics). A total of 870 (526 male, 344 female)
samples were used in linkage analysis of T2D and 846 (511 male,
335 female) samples were used in linkage analysis of lipid levels
after excluding those with call rate ,95%, relationship errors,
gender errors, and those with missing phenotypes.
Error Checking and Data Handling
A variety of statistical software was used to complete this study.
To set up the files for analysis, we extensively used the statistical
Table 2. Description of SDS Pedigrees.
Phenotyped*
Genotyped and phenotyped for
T2D**
Genotyped and phenotyped for
lipid levels**
Total Male Females Total Male Females Total Male Females
Number of families 338 – – 321 _ _ 316 _ _
Family size 6.51(*) – – 2.71(**) _ _ 2.68 _ _
Generations (average) 2.46 – – 2.49 _ _ 2.49 _ _
Number of individuals in pedigrees 2,199(*) 1248 951 870(**) 526 344 846(**) 511 335
Founders 979(*) – – 85 _ _ 82 _ _
Number of affecteds in pedigrees 1,202(*) 710 492 685 412 273
Number of individuals with blood available 1,115 684 431
Number of affecteds with blood available 868 530 338
Number of unaffected with blood available 247 154 93
*—including deceased; **—excluding deceased.
doi:10.1371/journal.pone.0021188.t002
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several steps. To check for inconsistencies in the self-reported
family structures, we carried out relationship testing using PREST
[20] and RELPAIR [21,22]. PEDCHECK [23] was used to detect
Mendelian inconsistencies in genotype combinations within a
family. PEDSTATS (version 0.6.9) [24] was used to obtain counts
of individuals included in the analysis.
Phenotype Normalization and Adjustment for Covariates
To adjust for the confounding effects of environmental influence
on the lipid traits, we included information on age, age
2 sex, BMI,
dietary and lifestyle factors (smoking, alcohol consumption, and
physical activity), socio-economic status (education and job-grade)
as covariates. To select significant covariate, both stepwise
regression and backward elimination were used in genetic models.
Significant covariates considered for selection in the model were
age, age
2, sex, job grade, level of alcohol consumption.
Additionally, analysis was performed including and excluding
BMI in the model despite its elimination in stepwise regression.
Univariate analysis was performed to obtain summary statistics for
each trait (online supplementary Table S2). A classical multiple
linear regression model: Y~Xbze, was used where Y is the
response and X is the design matrix and b is the vector of
regression coefficients. To reduce collinearity between age and
age
2, these variables were mean centered. Since most of the traits
were right skewed, they were transformed using the Box-Cox
transformation method (Figure S1). Box-Cox method provides
optimal value of the transformation parameters and increases the
applicability and usefulness of statistical techniques based on the
normality assumption and can significantly improve the linear fit
of Y against X . After transformation we checked for the outliers.
Regression parameters were estimated after exclusion of outliers
(points outside of mean 63 SD), and residuals were computed for
all participants. After building the model, the data were rechecked
for further outliers using the jackknife method. Influential
observations also were taken care of. High Leverage point and
Cook’s distance for each observation were also measured. To test
the significance of the parameters, a significance level of 0.05 was
used throughout the analyses. To sample a set of putatively
unrelated individuals for the regression analysis, we took all
phenotyped founders. If a family had no phenotyped founders,
then we sampled one phenotyped non-founder from that family.
Although BMI was not a significant covariate in step-wise
selection, the entire QTL-ALL analyses were performed both
including and excluding BMI as a covariate in the model.
Genome-wide Linkage Analysis for T2D
We used the Sall statistic [25] as implemented in Merlin [26] to
perform linkage analysis for the trait T2D. This non-parametric
method has excellent power and is robust across a wide variety of
disease models [27,28]. Using FastSLINK [29,30,31], we
simulated genetic data, for a 2-allele marker for an allele frequency
of 0.01 and a penetrance vector of (0.054, 0.50, 0.70), which
implies that the relative risk to siblings, ls, is a relatively low 1.49.
Then a Sall LOD score was computed using Merlin. From this
simulated data we have 98% power to detect a LOD .=2; and
90% to detect a LOD .=3 in this cohort. Notably, these power
estimates are conservative as we excluded the biggest two families
which were too complex to run through Merlin.
QTL-ALL Analysis for Mapping Lipid Traits
In this study, families containing individuals affected by T2D
are preferentially over-sampled, so this sample is non-randomly
ascertained with respect to T2D. Therefore, to the extent that lipid
traits are correlated with T2D status, the sample is also non-
randomly ascertained with respect to the lipid traits. Thus, it
would not be appropriate to use the usual variance-component
based linkage analysis methods on these data. Instead we used
score-based linkage statistics as implemented in the QTL-ALL
program for this data set [32]. We decided to use the statistic
SCORE.MAX, which is recommended in most circumstances,
and which has been shown to work well even on non-randomly
ascertained data. The current version of QTL-ALL can handle
only nuclear family pedigrees. So the Mega2 program was used to
convert the multi-generation families to single generation nuclear
families [33].
Results
Family Structure Error, Gender Error and Genotype Error
Checking
Family structure data and X-linked genotypes at 27 markers
were combined to detect possible gender errors by looking for
males who are more heterozygous than expected and females who
are more homozygous than expected. Five males were heterozy-
gous at more than two markers; 16 women were more than 80%
homozygous. All suspect participants were rechecked to ensure
there was no misreporting of gender. We used RELPAIR and
PREST to check the accuracy of self-reported family relationships.
Misclassification of relationship for half-siblings as full-sibling, and
unrelated as cousins, were detected and resolved. Participants with
unresolved relationship errors were removed from families before
analysis. We also used PEDCHECK to check Mendelian
inconsistencies at each marker and erroneous data were omitted
from further analysis. Table 1 shows the clinical and physical
characteristics of the SDS participants used in the analysis.
Linkage Analysis for T2D
As shown in online Figure S1, non-parametric multipoint
linkage analysis did not show any chromosomal region to be
significantly associated with T2D in this Sikh cohort. Adjusting for
age, BMI, and gender did not alter linkage signal significantly and
consequently were not included as covariates in the results
presented. We found little evidence of linkage with T2D with
maximum LOD of 1.24 reached on chromosome 2p24 near
microsatellite markers SRAP and X130YG9P. No other region
revealed any signal (LOD .1.00) associated with T2D in these
families.
Influence of Environmental Factors on Lipid Traits
Univariate analysis of the lipid traits showed some individuals
with very high or very low outlier values, which were removed
from the analysis. As needed a Box-Cox transformation was used
to make the error distribution of the data more normal (online
Figure S2). Regression models were then fitted for the
transformed traits. In the variable selection step, in most cases
forward stepwise-regression and backward elimination agreed with
each other. Table 3 shows the final models selected after
detecting the significant covariates for each lipid trait analyzed.
Total serum cholesterol levels were influenced by economic status.
The correlation between VLDL cholesterol and triglycerides was
very high (0.98) and level of alcohol consumption was a significant
factor for influencing both serum triglycerides and VLDL-
cholesterol levels. Gender was a significant covariate for serum
HDL cholesterol, and age, age
2, and socio-economic status (job
grade) were significant predictors of serum LDL cholesterol levels
(Table 3). All the estimated coefficients are presented in online
Table S1. High leverage points and Cook’s distance were
Linkage Scan for Diabetes and Lipids in Sikhs
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observations. After removing the maximum Cook’s distance
points, there was no significance change in the model. Calculated
jackknife statistics was also within the acceptance region. Residuals
of each trait were calculated and these residuals were used for the
final QTL-ALL analysis.
QTL-ALL Analysis for Mapping Lipid Traits
QTL-ALL analysis, using the Score.Max statistics, was
performed for the five quantitative traits. An overview of the
linkage results for the significant signals associated with serum lipid
associated traits is given in Figure 1 and Table 4. Several QTLs
with p#0.005 were detected on chromosomes 5p, 9q, 10q, 10p,
and 22q. The strongest linkage signal (p=0.0011) was detected on
chromosome 10q21.2 near D10S1225 for serum HDL cholesterol.
Suggestive evidence of linkage for total cholesterol was observed
on chromosome 5 near marker D5S2488 (p=0.0031), and on
chromosome 22 near marker TCTA015M (p=0.0016). Two
signals, one near marker D9S1122 (p=0.0039) on chromosome 9
and other near D10S1426 (p=0.0045) on chromosome 10, were
detected for LDL cholesterol. A peak for HDL (p=0.031) was
seen near marker D9S934 on chromosome 9. No significant signal
for serum triglycerides was observed (online Figure S3). Because
obesity is a major risk factor for CVD and T2D risk, and affects
lipid levels, we also tested linkage signals including and excluding
BMI. Our results did not change after including BMI in the
model.
Discussion
Our study represents the first large scale genome-wide effort to
identify chromosomal regions with putative loci affecting T2D and
lipid traits in a unique community of Asian Sikhs from Northern
India. This diabetic cohort from a genetically homogenous
subgroup was collected with the initial goal of identifying T2D
predisposing genes. However, the results of our non-parametric
linkage scan did not identify any chromosomal region to be
significantly linked to T2D (online Figure S1). Note that the
non-parametric method for linkage (used in our study) only
considers allele sharing between affected individuals, therefore, the
ambiguous phenotype of unaffected members is unlikely to have
led to the failure to detect linkage in this large sample. These
results reaffirm the highly complex nature of T2D phenotype.
Essentially, our study failed to identify genes associated with T2D
even when a homogenous population was used to control genetic
heterogeneity associated with T2D phenotype and a sample
collected from one geographic location was used to reduce
environmental heterogeneity. These finding suggest that the genes
responsible for T2D in Sikhs have small effects, as seen in other
ethnic groups, and are difficult to detect using linkage analysis. It
can be argued that in comparison to random-mating population,
higher identity by descent (IBD) sharing in this inbred population
might have reduced the power of detecting significant linkage. In
this scenario, one would expect to see increased average IBD
leading to false positive indications of linkage. On the contrary, we
found the opposite with no substantial increase in IBD among
affected individuals and thus no linkage. At the same time, we
believe that our linkage data may still contain considerably useful
information that could enable the discrimination of causal variant
from a near-by variant that is merely in linkage disequilibrium
(LD) [34]. Interestingly, our case-control association studies have
confirmed some Caucasian GWAS loci (TCF7L2, PPARG,
KCNJ11, FTO and KCNQ1) associated with T2D in this population
[35,36,37,38]. Therefore, further fine mapping especially in the
elevated regions using high-density SNP panel and whole genome
sequencing may identify rare and functional variants with large
effects contributing to T2D. These Investigations also may answer
the questions of ‘missing heritability’ which is expected to lie in the
‘rare’ variants and which the GWA studies are unable to explain
[39].
The other aim of this investigation was to identify genomic
regions affecting lipid-related phenotypes in this cohort. We
performed QTL-ALL analysis on this non-randomly ascertained
dataset, which revealed several suggestive linkage signals associ-
ated with serum lipid levels (Table 4). Classical multiple linear
regression models were used to adjust for environmental effects on
the serum lipid traits. In view of strong environmental component
associated with T2D and lipid metabolism, we have carefully
analyzed the environmental factors, particularly the unique life
style factors such as diet, physical activity, obesity, job status, socio-
economic status, gender, and medication that could potentially
influence these traits. As explained in the Results section, the
significant covariates with potential to modify linkage effect were
identified and included in the analysis model. The strongest
evidence of linkage (p=0.0011) for HDL cholesterol was detected
on chromosome 10q21.1–21.2. Suggestive evidence of linkage to
ApoA-I was observed on chromosome 10q21.1 in the Quebec
Family Study (QFS) [40]. The same region containing proto-
cadherin 15 (PCDH15) gene (10q21.1) has been associated with
multiple lipid traits in Finnish and Dutch multigenerational
dyslipidemic families [41]. Another strong GWAS candidate gene
linked with metabolic traits is solute carrier family 16, member 9
(SCL16A9) that also maps to chromosome 10q21.2 [42]. It is a
proton-linked monocarboxylate transporter and catalyzes the
rapid transport of many monocarboxylates across the plasma
membrane. Chromosome 10 also carried a signal for LDL
cholesterol at 10p11.23 (p=0.0045) in our study. The closest
candidate gene at this region is KIAA1462 (10p11.23) that encodes
a yet uncharacterized protein. However, a recently published
GWAS showed an unambiguous evidence for association of
rs3739998 (p=7.2610
28) within this gene with CVD and
myocardial infarction in German MI Family cohort (GerMIFS)
III (KORA) [43]. Interestingly, some common variants in
PCDH15 and SCL16A9 and KIAA1462 genes are also associated
with multiple lipid traits including HDL cholesterol, LDL
cholesterol, and triglycerides ( p values of 0.004 to 0.0001) in
our provisional results of lipid GWAS being performed on the
population originated from the same Asian Indian community
(unpublished results).
A linkage peak for total serum cholesterol (p=0.0031) was
detected near marker D5S2488 at the proximal region of
chromosome 5p15.33. This region was previously linked to LDL
cholesterol in the NHLBI Family Heart Study [44] and HDL
Table 3. Final model variables in the five lipid traits.
Covariate Trait
Job
grade
Alcohol
consumption Sex Age Age
2
Total Cholesterol *
Triglycerides *
HDL Cholesterol *
LDL Cholesterol * * *
VLDL Cholesterol *
*represents significant covariate used for each lipid trait.
doi:10.1371/journal.pone.0021188.t003
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PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e21188Figure 1. Genome-wide linkage scan to detect susceptibility loci for five blood lipid phenotypes using QTL-ALL analysis using 316
pedigrees. Linkage plots show significant signals at four chromosomal regions with allele sharing LOD (2log10 p value) on Y axis and chromosome
distance (cM) on X axis. Significant linkage includes chromosome 5 near marker D5S2488 (p=0.0031) for total cholesterol; chromosome 9 near
marker D9S1122 (p=0.0039) for LDL cholesterol; chromosome 10q21.2 near D10S1225 (p=0.0011) for HDL cholesterol; and chromosome 22 near
marker TCTA015M (p=0.0016) for total cholesterol.
doi:10.1371/journal.pone.0021188.g001
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Blood Pressure Study [45]. Additionally, meta-analysis of linkage
scans from four studies revealed a modest signal for LDL
cholesterol (LOD 1.6) on chromosome 5p15.33 [46]. The
suggestive linkage for LDL cholesterol at 9q21.13 near marker
D9S1122 in our cohort was also associated with the triglyceride
phenotype in a linkage study performed in families with
myocardial infarction [47].
The linkage signal at chromosome 22q13.32 near marker
TCTA015M (p=0.0016), detected for total cholesterol was linked
with familial hypercholesterolemia in a Utah study [48]. The
chromosomal region 22q11–13 was also reported to effect HDL
cholesterol in the Old Order Amish [49]. Notably, the strongest
candidate gene in this region is PPARa, which is a ligand-activated
nuclear transcription factor and controls extracellular and
intracellular lipid metabolism, and also inhibits progression of
atherosclerotic lesions [50]. Lipid-lowering drugs of fiberate class
are synthetic ligands of ppara [51]. Variants in this gene were
reported to be associated with T2D and CVD [52]. Another gene
CELSR1 (located at 22q11–13) is associated with ischemic stroke in
recent Japanese GWAS [53]. Furthermore, a single nucleotide
polymorphism (SNP) near CELSR2 on chromosome 1p13
(homologous to CELSR1) is associated with LDL cholesterol and
myocardial infarction in a meta-analysis study by Myocardial
Infraction Genetics Consortium [54].
Our study does not represent a common replication attempt to
identify lipid loci in an independent population. Rather, this
investigation has been carefully carried out in this unique family-
based cohort using a conservative statistical approach applying
score-based statistics to map quantitative lipid traits in a non-
randomly ascertained dataset. Exceeding our expectations, this
study has identified linkage regions, primarily HDL cholesterol
(10q21.1–21.2) and total cholesterol (22q13.32) that were
previously reported for lipid traits or CVD. The most interesting
part of this study is that some of these linkage signals also harbor
important candidate loci (e.g., KIAA1462, PCDH15, PPARa,
SLC16A9, and CELSR1) implicated with lipid traits in recent
GWAS and meta-analysis studies and also some of these regions
overlap with prior linkage studies [55,56,57]. Therefore, our
findings suggest that these regions might contain some novel genes
for blood lipids rather than chance findings, and perhaps some of
the loci may have larger effects in this Khatri Sikh cohort.
Notably, the presence of HDL cholesterol signal on chromosome
10q21.2 is particularly important in view of low HDL cholesterol-
associated CVD risk in Asian Indian men, in general, and may
strongly relate to gene-environmental interaction which is
enhanced by rapidly emerging western lifestyle [58,59]. Further
fine mapping with more efficacious strategy using SNP-based
arrays (which would also help determine LD over small intervals),
sequencing, and functional studies should allow rapid detection of
novel target genes of therapeutic importance under these
candidate regions.
Conclusions
Unlike previous studies, our genome-wide linkage scan could
not identify any significant chromosomal region associated with
T2D in this unique family cohort of Punjabi Sikhs with increased
risk to developing T2D and cardiovascular illnesses. Our study,
however, for the first time provides an evidence of linkage for loci
controlling quantitative lipid traits at four chromosomal regions in
this Asian Indian population. The strongest linkage signal was seen
for HDL cholesterol on chromosome 10q21.2. Our data also
revealed linkage signals for total cholesterol on chromosome
5p15.33 and 22q13.32, and for LDL cholesterol on 10p11.23 and
9q21.13. Some of these regions have been linked to lipid-related
traits in recent GWA studies and contain other plausible candidate
genes. The strongest peak for HDL cholesterol (p=0.0011 at
10q21.2) suggests that this region may contain novel gene(s)
influencing serum HDL cholesterol levels and other lipid traits.
Further denser and more informative genotyping in each of these
regions would be important to discover functional loci influencing
blood lipids.
Supporting Information
Figure S1 Genome-wide non-parametric linkage scans for type
2 diabetes using 321 diabetic pedigrees and 398 microsatellite
markers (9.26 cM). Individual plot shows linkage signals (Kong
and Cox LOD score) on Y axis and microsatellite markers on X
axis. None of the chromosome regions revealed any signal
associated with T2D in these pedigrees.
(TIF)
Figure S2 Plot of Box-Cox coefficient lambda and the
distribution of five quantitative traits including total cholesterol,
triglycerides, HDL cholesterol, LDL cholesterol, and VLDL
cholesterol before and after transformation.
(TIF)
Figure S3 Genome-wide autosomal linkage scan for five blood
lipid phenotypes. Individual plot shows allele sharing LOD
(2log10 p value) on Y axis and chromosome distance (cM) on
X axis.
(TIF)
Table S1 Linear regression model for quantitative traits.
(DOC)
Table 4. Susceptibility regions for serum lipid levels with Score.Max p values of #0.005.
Trait Chromosome
Cytogenetic
position
Physical
Position* Closest Marker
Genetic
Position (cM) Score.Maxp Value
Total Cholesterol 5 5p15.33 180390 D5S2488 0.00 0.0031
LDL Cholesterol 9 9q21.13 78878414 D9S1122 75.88 0.0039
LDL Cholesterol 10 10p11.23 30535660 D10S1426 65.61 0.0045
HDL Cholesterol 10 10q21.1 57199892 D10S1221 84.44 0.0041
HDL Cholesterol 10 10q21.2 64425005 D10S1225 89.69 0.0011
Total Cholesterol 22 22q13.32 47925896 TCTA015M 66.96 0.0016
*NCBI Build 36.1 positions from the UCSC browser.
doi:10.1371/journal.pone.0021188.t004
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